Synevo Central Labs
Synevo Central Labs is a Belgium-based, privately-held operator of what it describes as the largest wholly-owned, GCLP-accredited network of central laboratories in Europe, providing harmonized analytical services to biopharmaceutical sponsors and CROs running multi-country clinical trials.
- Company typePrivate
- Founded1996
- HeadquartersWaterloo, Belgium
- Headcount—
- GTM typeB2B
- OfferingServices
What Synevo Central Labs does
Synevo Central Labs, founded in 1996 and headquartered in Waterloo, Belgium, describes itself as the largest wholly-owned, fully-harmonized and GCLP-accredited network of central laboratories in Europe. The company provides centralized analytical laboratory services to support clinical trials conducted by biopharmaceutical sponsors and contract research organizations, including assay validation, biomarker testing, and harmonized sample processing across multiple European geographies under a single quality framework.
Operationally, the firm's value proposition rests on GCLP compliance, pan-European harmonization of methods and reference ranges, and integrated sample logistics — characteristics that allow a single protocol to be run consistently across countries. Its "wholly-owned" positioning implies captive infrastructure ownership rather than a federated or partner-driven model, which is typically required to maintain unified SOPs across a multi-country network. The company operates in a for-profit, privately-held structure with no public ticker disclosed in the source data.
The business model is consistent with B2B central laboratory economics: long-cycle clinical trial contracts priced per sample/assay, anchored by regulated quality systems and protocol-level switching costs. No pricing details, customer logos, segment splits, or revenue figures are disclosed in the available sources, and the company's primary website (synevo-centrallabs.eu) is currently suspended, limiting visibility into current product portfolio, customer roster, and commercial terms. No headcount, partnership, funding, M&A, or leadership data are available, which materially constrains both diligence and forecasting.
Synevo Central Labs firmographics
Firmographics- Name
- Synevo Central Labs
- Website
- https://synevo-centrallabs.eu
- Company type
- Private
- Founded year
- 1996
- Short description
- Synevo Central Labs is a Belgium-based, privately-held operator of what it describes as the largest wholly-owned, GCLP-accredited network of central laboratories in Europe, providing harmonized analytical services to biopharmaceutical sponsors and CROs running multi-country clinical trials.
- Ownership category
- akta.pro rank
Synevo Central Labs industry classification
Industry- Product category
- Central Laboratory Services
- NAICS
- Medical and Diagnostic Laboratories (6215), Medical Laboratories (621511)
- SIC
- Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Central Laboratory Services (Core Lab Operations) (HLAGAEAA)
- akta.pro secondary industries
- Clinical Research & Trial Central Laboratories (HLAFAMAL), Central Laboratory & Clinical Trial Testing CROs (HLAGAAAE), Laboratory Quality & GLP/GCLP Compliance (HLAGAKAK)
Keywords
Where Synevo Central Labs is headquartered
LocationHeadquarters
- HQ city
- Waterloo
- HQ country
- Belgium
- HQ region
- Europe
Markets served
Synevo Central Labs business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Supply Chain, Technology or R&D
Synevo Central Labs product offering
Product offeringCore offering
Synevo Central Labs operates the largest wholly-owned, fully-harmonized and GCLP-accredited network of central laboratories in Europe, providing clinical trial sample testing, biomarker analysis, and integrated laboratory services to pharmaceutical, biotechnology, and clinical research clients. The network delivers standardized, multi-site laboratory capabilities conforming to Good Clinical Laboratory Practice requirements.
Differentiator
Problem solved
Functional benefit
Companies that use Synevo Central Labs
Customer profileIdeal customer profiles1 record
Synevo Central Labs technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Synevo Central Labs partnerships and signals
Strategic signalScale indicators1 record
Expansion highlights1 record
Synevo Central Labs competitors and assessment
Company assessmentBroad incumbents
- Syneos Health: Syneos Health is a global biopharmaceutical services organization offering clinical development and commercialization services. While not a pure central lab, it competes for sponsor trial outsourcing budgets that include central laboratory components.
- Medpace: Medpace is a mid-to-large global CRO that operates its own central laboratory as part of a broader clinical trial services portfolio. It is a broader incumbent peer because it competes for the same clinical trial mandates while offering a wider service suite than a pure central lab.
- Thermo Fisher Scientific (PPD Central Labs): Thermo Fisher Scientific, through its PPD clinical research business, operates central laboratory services as part of a much broader life sciences tools and clinical research portfolio. It is a broad incumbent peer that competes for global central lab and integrated clinical trial mandates.
Direct peers
- ACM Global Laboratories: ACM Global Laboratories is a specialty central lab offering clinical trial testing and bioanalytical services with global reach. It is comparable to Synevo Central Labs in serving global clinical trials with harmonized lab testing capabilities.
- MLM Medical Labs: MLM Medical Labs is a European central laboratory focused on GCLP-compliant testing for clinical trials. It is a direct European peer, comparable in scale focus and sponsor client mix to Synevo Central Labs.
- Eurofins Central Laboratory: Eurofins Central Laboratory provides global central lab services with European roots, including GCLP-compliant testing and biomarker capabilities for clinical trials. It is a direct competitor in the European central lab market and competes for pan-European harmonized trial mandates.
- ICON Central Laboratories: ICON, following its PRA Health Sciences acquisition, operates central laboratory services supporting global clinical trials. It directly competes with Synevo Central Labs for harmonized central lab contracts and global sample logistics.
- Cerba Research: Cerba Research is a clinical research central and specialty laboratory headquartered in Europe, providing GCLP-compliant central lab services, biomarker and genomic testing for clinical trials. It is a direct European peer competing for the same sponsor central lab mandates.
- Q² Solutions (IQVIA Central Labs): Q² Solutions is a global central laboratory joint venture historically tied to IQVIA, offering harmonized GCLP-compliant central lab services for clinical trials worldwide. It is a direct peer to Synevo Central Labs in core central lab operations, sample logistics, and bioanalytical testing for global trials.
- Labcorp Central Labs (Fortrea): Fortrea (post the Labcorp Drug Development spin-off) operates one of the largest global central laboratory networks serving clinical trials. It is directly comparable to Synevo Central Labs in core central lab testing, specialty biomarker services, and global harmonized lab support.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks5 records
Key highlights4 records
Customer concentration
Synevo Central Labs social profiles
Digital presenceSynevo Central Labs financial estimates
Financial estimateRevenue estimate
Valuation estimate
Synevo Central Labs leadership team
Management profileNumber of profiles
Synevo Central Labs funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Synevo Central Labs M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Synevo Central Labs
What does Synevo Central Labs do?
Synevo Central Labs operates the largest wholly-owned, fully-harmonized and GCLP-accredited network of central laboratories in Europe, providing clinical trial sample testing, biomarker analysis, and integrated laboratory services to pharmaceutical, biotechnology, and clinical research clients. The network delivers standardized, multi-site laboratory capabilities conforming to Good Clinical Laboratory Practice requirements.
When was Synevo Central Labs founded?
Synevo Central Labs was founded in 1996.
Where is Synevo Central Labs based?
Synevo Central Labs is headquartered in Waterloo, Belgium, in the Europe region.
Who are Synevo Central Labs's main competitors?
Broad incumbents on record are Syneos Health, Medpace and Thermo Fisher Scientific (PPD Central Labs). Direct peers are ACM Global Laboratories, MLM Medical Labs, Eurofins Central Laboratory, ICON Central Laboratories, Cerba Research, Q² Solutions (IQVIA Central Labs) and Labcorp Central Labs (Fortrea).
Does Synevo Central Labs have an API?
No public API is recorded for Synevo Central Labs.
What industry is Synevo Central Labs in?
Synevo Central Labs's product category is Central Laboratory Services. Its primary akta.pro industry code is HLAGAEAA, Central Laboratory Services (Core Lab Operations), with a secondary code of HLAFAMAL, Clinical Research & Trial Central Laboratories. Its NAICS code is 6215 and its SIC code is 8071.